FDA clears Varians motion-tracking system

Varian Medical Systems has received FDA 510(k) clearance for its motion tracking transponder.

The Surface Beacon Transponder is designed for use with the Varian Calypso system as a real-time tracking device capable of monitoring motion during radiotherapy treatments for indications anywhere in the body. It is placed temporarily on the skin to track respiratory and other patient motion during radiotherapy.

Varian acquired Calypso in October 2011 to extend its range of real-time tracking tools.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup